Impact of cytochrome P450 3A5 expression on clinical outcomes in renal transplant recipients receiving tacrolimus-based immunosuppression

Table 1 Clinical characteristics of renal transplant patients between expressor and non-expressors

Variable	Expressors (n = 35)		Non-expressors (n = 60)		P value
	n	%	n	%
Gender
Male	27	77.1	48	80	0.7431
Female	8	22.9	12	20
Age group
10-30 years	13	37.1	18	30.0	0.7399
31-50 years	17	48.6	31	51.7
> 50 years	5	14.3	11	18.3
Comorbidities
Diabetes	6	17.1	10	16.7	0.9525
Hypertension	21	60.0	30	50.0	0.3483
Donor
Father	2	5.7	3	5.0	0.2172
Mother	8	22.9	16	26.7
Wife	3	8.6	4	6.7
Other	22	62.9	37	61.7
Kidney
Live	30	85.7	53	88.3	0.7123
Cadaveric	5	14.3	7	11.7